|
Jul 14
|
Winn CIPP Welcomes Cohort 4 Medical Students Focused on Connecting Communities to Clinical Research
|
|
Jul 14
|
Invenra Welcomes Dr. Alan J. Korman to Its Scientific Advisory Board
|
|
Jul 14
|
3 Top Dividend Stocks to Maximize Your Retirement Income
|
|
Jul 14
|
Should SPDR Russell 1000 Low Volatility Focus ETF (ONEV) Be on Your Investing Radar?
|
|
Jul 14
|
Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?
|
|
Jul 14
|
What to Expect From Bristol-Myers Squibb's Q2 2025 Earnings Report
|
|
Jul 13
|
Can Bristol-Myers Squibb Company (BMY) Provide Stable Long-Term Income?
|
|
Jul 12
|
FDA willing to trade faster drug reviews for lower prices, Bloomberg reports
|
|
Jul 11
|
Big pharma's multiple looming patent cliffs: What to know
|
|
Jul 11
|
Why Bristol-Myers Squibb (BMY) Shares Are Sliding Today
|
|
Jul 11
|
ABBV or BMY: Which Biopharma Giant Has Better Prospects for Now?
|
|
Jul 11
|
2 Top Stocks Down 16% and 17% This Year to Buy and Hold
|
|
Jul 11
|
Psoriatic Arthritis Market Report 2025-2035 | Competitive Analysis of AbbVie, UCB, Pfizer, Johnson & Johnson, Eli Lilly and Co, Bristol-Myers Squibb, Affibody, Amgen, Boehringer Ingelheim, Sun Pharma
|
|
Jul 10
|
Anal Cancer Market Research Report 2025-2035 with Competitive Profiles of Incyte, BioMimetix, Bristol Myers Squibb, and AstraZeneca
|
|
Jul 9
|
Bristol Myers Squibb (BMY) Surpasses Market Returns: Some Facts Worth Knowing
|
|
Jul 9
|
Recent Agreements Set To Bolster BioNTech SE (BNTX)’s Oncology Arm
|
|
Jul 9
|
Bristol-Myers Squibb Company (BMY) Announces New Clinical Trial for Breast Cancer Drug Iza-bren
|
|
Jul 9
|
Will Recent Label Expansions of Opdivo Help BMY Gain Momentum?
|
|
Jun 13
|
Tariffs Create Most Patriotic Earnings Season Yet as US Firms Pander to Trump
|
|
Jun 12
|
Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD™ Agents and BCL6 Ligand-Directed Degrader at EHA 2025
|